LitAlert ~~ GeneLit.com

    • Identification of the most common BRCA alterations through analysis of germline mutation databases: Is droplet digital PCR an additional strategy for the assessment of such alterations in breast and ovarian cancer families?
    • Lavoro A, Scalisi A, Candido S, Zanghì GN, Rizzo R, Gattuso G, Caruso G, Libra M, Falzone L.
    • Int J Oncol. 2022 May;60(5):58. doi: 10.3892/ijo.2022.5349. Epub 2022 Apr 6.
    • BAP1-defficient breast cancer in a patient with BAP1 cancer syndrome.
    • Blatnik A, Ribnikar D, Šetrajcic Dragoš V, Novakovic S, Stegel V, Grcar Kuzmanov B, Boc N, Peric B, Škerl P, Klancar G, Krajc M.
    • Breast Cancer. 2022 Apr 5. doi: 10.1007/s12282-022-01354-0. Epub ahead of print.
    • [Application of next-generation sequencing in detection of BRCA1/2 and homologous recombination repair pathway multi-genes germline mutation and correlation analysis].
    • Chen YL, Zhuo ZL, Liu C, Xie F, Yang ZY, Liu PF, Wang S, Zhao XT.
    • Zhonghua Yu Fang Yi Xue Za Zhi. 2022 Mar 6;56(3):302-311. Chinese. doi: 10.3760/cma.j.cn112150-20211208-01132.
    • [Article in Chinese]
    • Efficacy and safety of poly (ADP-ribose) polymerase inhibitors therapy for BRCA-mutated breast cancer: A systematic review and meta-analysis.
    • Zhang M, Yu X, Wang J, Li Y, Cao L.
    • J Cancer Res Ther. 2021 Dec;17(7):1672-1678. doi: 10.4103/jcrt.jcrt_2085_21.